What is tocilizumab?
Tocilizumab is a monoclonal antibody that is approved for the treatment of Giant Cell Arteritis (GCA).
How does tocilizumab work?
Tocilizumab works by blocking IL-6. IL-6 is an immune system protein that promotes inflammation.
How is tocilizumab given?
Tocilizumab can be self-administered as an injection (weekly or every 2 weeks) or given intravenously at an infusion center (monthly).
Side effects:
We pay particular attention to liver function tests, lipids, and blood counts when using tocilizumab.
All immunosuppressants require regular monitoring in the form of blood tests, in-person assessments, and prompt attention to any signs or symptoms of infection.
